Research & Development
Scientific Overview
Scientific Presentations
Scientific Advisory Board
![]()
Clinical Studies
Clinical Trial Participation
Clinical Trial Sites
![]()
Pre-Clinical
Research
![]()
Product Pipeline![]()
Scientific Reports

![]() |
![]() |
|||||||||
| Brain: The Nerve Tissue Group | ||||||||||
|
5 Million People Suffer from Strokes in the U.S. CVBT has focused most intensely on developing new treatments that can stimulate new blood vessel growth into ischemic muscle tissues. However, blocked blood vessels can also severely injure other tissue types including nerve and neural tissue. Stroke results from the same basic atherosclerotic process that causes coronary artery disease, but occurs in vessels that supply brain cells with blood. Review a scientific summary of the most current research results in this area.
Use of
this site constitutes agreement to our Terms and Conditions Some content on this site requires the free Adobe
Reader. | ||||||||||
2/24/2009
CVBT Opens Florida and Arizona Sites for Its ACORD Phase II Heart Trial
1/8/2009
CVBT Opens Two Additional Sites for Its ACORD Phase II Heart Trial
12/11/2008
CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial
11/25/2008
CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease